 |
Taking GLP-1s is linked to a decline in physical activity
26 Jun 2026
People taking GLP-1 weight loss medications such as Ozempic, Wegovy, Mounjaro and Zepbound
may be losing weight, but they’re also becoming less physically active, according to new
research presented at the ENDO 2026 annual meeting of the Endocrine Society
|
 |
|
 |